Auriclosene

DB12197InvestigationalSmall molecule

Auriclosene has been used in trials studying the treatment of Impetigo, Bacterial Conjunctivitis, Asymptomatic Bacteriuria, and Adenoviral Conjunctivitis.

Formula / weight: C₄H₉Cl₂NO₃S · 222.08 g/mol (avg)
Code names: NVC-422

Resolves to

Compound

UNIIBKR7Y95229CAS846056-87-9ChEMBLCHEMBL1207907PubChem11708365

Structure

InChIKeyQYNRGGHZWCUZLK-UHFFFAOYSA-NSMILESCC(C)(CS(O)(=O)=O)N(Cl)Cl

What you can answer from here — as of February 21, 2021

6Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Auriclosene, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account